Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P David Mozley

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
Molecular Imaging and Biology|May 25, 2005
Weaving single photon imaging into new drug developmentP David Mozley
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|March 4, 2003
Imaging-based measures of disease progression in clinical trials of disease-modifying drugs for Alzheimer diseaseBrandy Matthews, Eric R Siemers, P David Mozley
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|November 13, 2002
Biomarkers in psychotropic drug developmentSaeeduddin Ahmed, P David Mozley, William Z Potter
Physics in Medicine and Biology|January 21, 2006
Comparison of region-of-interest analysis and human observers in the diagnosis of Parkinson's disease using [99mTc]TRODAT-1 and SPECTPaul D Acton, Andrew Newberg, Karl Plössl, et al.
The American Journal of Psychiatry|September 30, 2003
Greater availability of brain dopamine transporters in major depression shown by [99m Tc]TRODAT-1 SPECT imagingDavid J Brunswick, Jay D Amsterdam, P David Mozley, et al.
Clinical Nuclear Medicine|May 23, 2007
Dopamine transporter binding in smokers and nonsmokersAndrew Newberg, Caryn Lerman, Nancy Wintering, et al.
Clinical Imaging|September 15, 2015
Yttrium-90 microsphere radioembolotherapy in a patient with spontaneously ruptured hepatocellular carcinomaRonald S Winokur, Adam D Talenfeld, P David Mozley, et al.
Clinical Nuclear Medicine|March 27, 2002
Chest tube insertion as a potential source of false-positive FDG-positron emission tomographic resultsHongming Zhuang, Mary E Cunnane, Nasrin V Ghesani, et al.
Journal of the National Cancer Institute|January 1, 2019
Statistical Considerations for Planning Clinical Trials with Quantitative Imaging BiomarkersNancy A Obuchowski, P David Mozley, Dawn Matthews, et al.
Nuclear Medicine Communications|December 6, 2024
Safety observations in neuroblastoma patients undergoing 18 F- m FBG PETNeeta Pandit-Taskar, Ellen Basu, Eloisa Balquin, et al.
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Molecular Imaging and Biology|May 25, 2005
Weaving single photon imaging into new drug developmentP David Mozley
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|March 4, 2003
Imaging-based measures of disease progression in clinical trials of disease-modifying drugs for Alzheimer diseaseBrandy Matthews, Eric R Siemers, P David Mozley
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|November 13, 2002
Biomarkers in psychotropic drug developmentSaeeduddin Ahmed, P David Mozley, William Z Potter
Physics in Medicine and Biology|January 21, 2006
Comparison of region-of-interest analysis and human observers in the diagnosis of Parkinson's disease using [99mTc]TRODAT-1 and SPECTPaul D Acton, Andrew Newberg, Karl Plössl, et al.
The American Journal of Psychiatry|September 30, 2003
Greater availability of brain dopamine transporters in major depression shown by [99m Tc]TRODAT-1 SPECT imagingDavid J Brunswick, Jay D Amsterdam, P David Mozley, et al.
Clinical Nuclear Medicine|May 23, 2007
Dopamine transporter binding in smokers and nonsmokersAndrew Newberg, Caryn Lerman, Nancy Wintering, et al.
Clinical Imaging|September 15, 2015
Yttrium-90 microsphere radioembolotherapy in a patient with spontaneously ruptured hepatocellular carcinomaRonald S Winokur, Adam D Talenfeld, P David Mozley, et al.
Clinical Nuclear Medicine|March 27, 2002
Chest tube insertion as a potential source of false-positive FDG-positron emission tomographic resultsHongming Zhuang, Mary E Cunnane, Nasrin V Ghesani, et al.
Journal of the National Cancer Institute|January 1, 2019
Statistical Considerations for Planning Clinical Trials with Quantitative Imaging BiomarkersNancy A Obuchowski, P David Mozley, Dawn Matthews, et al.
Nuclear Medicine Communications|December 6, 2024
Safety observations in neuroblastoma patients undergoing 18 F- m FBG PETNeeta Pandit-Taskar, Ellen Basu, Eloisa Balquin, et al.
Pageof 5